Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency

Ilpo Huhtaniemi, Outi Hovatta, Antonio La Marca, Gabriel Livera, Danielle Monniaux, Luca Persani, Abdelkader Heddar, Katarzyna Jarzabek, Triin Laisk-Podar, Andres Salumets, Juha S. Tapanainen, Reiner A. Veitia, Jenny A. Visser, Peter Wieacker, Slawomir Wolczynski, Micheline Misrahi

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

Primary ovarian insufficiency (POI) affects ∼1% of women before 40 years of age. The recent leap in genetic knowledge obtained by next generation sequencing (NGS) together with animal models has further elucidated its molecular pathogenesis, identifying novel genes/pathways. Mutations of >60 genes emphasize high genetic heterogeneity. Genome-wide association studies have revealed a shared genetic background between POI and reproductive aging. NGS will provide a genetic diagnosis leading to genetic/therapeutic counseling: first, defects in meiosis or DNA repair genes may predispose to tumors; and second, specific gene defects may predict the risk of rapid loss of a persistent ovarian reserve, an important determinant in fertility preservation. Indeed, a recent innovative treatment of POI by in vitro activation of dormant follicles proved to be successful.

Original languageEnglish
Pages (from-to)400-419
Number of pages20
JournalTrends in Endocrinology and Metabolism
Volume29
Issue number6
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

Primary Ovarian Insufficiency
Molecular Biology
Genes
Fertility Preservation
Genetic Heterogeneity
Genome-Wide Association Study
Genetic Counseling
Meiosis
Therapeutics
DNA Repair
Animal Models
Mutation
Neoplasms

Keywords

  • exome
  • genetics
  • in vitro activation of dormant follicles
  • meiosis genes
  • ovary
  • primary ovarian insufficiency

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency. / Huhtaniemi, Ilpo; Hovatta, Outi; La Marca, Antonio; Livera, Gabriel; Monniaux, Danielle; Persani, Luca; Heddar, Abdelkader; Jarzabek, Katarzyna; Laisk-Podar, Triin; Salumets, Andres; Tapanainen, Juha S.; Veitia, Reiner A.; Visser, Jenny A.; Wieacker, Peter; Wolczynski, Slawomir; Misrahi, Micheline.

In: Trends in Endocrinology and Metabolism, Vol. 29, No. 6, 01.06.2018, p. 400-419.

Research output: Contribution to journalReview article

Huhtaniemi, I, Hovatta, O, La Marca, A, Livera, G, Monniaux, D, Persani, L, Heddar, A, Jarzabek, K, Laisk-Podar, T, Salumets, A, Tapanainen, JS, Veitia, RA, Visser, JA, Wieacker, P, Wolczynski, S & Misrahi, M 2018, 'Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency', Trends in Endocrinology and Metabolism, vol. 29, no. 6, pp. 400-419. https://doi.org/10.1016/j.tem.2018.03.010
Huhtaniemi, Ilpo ; Hovatta, Outi ; La Marca, Antonio ; Livera, Gabriel ; Monniaux, Danielle ; Persani, Luca ; Heddar, Abdelkader ; Jarzabek, Katarzyna ; Laisk-Podar, Triin ; Salumets, Andres ; Tapanainen, Juha S. ; Veitia, Reiner A. ; Visser, Jenny A. ; Wieacker, Peter ; Wolczynski, Slawomir ; Misrahi, Micheline. / Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency. In: Trends in Endocrinology and Metabolism. 2018 ; Vol. 29, No. 6. pp. 400-419.
@article{656502911ae04e70908aaea4ae0991cd,
title = "Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency",
abstract = "Primary ovarian insufficiency (POI) affects ∼1{\%} of women before 40 years of age. The recent leap in genetic knowledge obtained by next generation sequencing (NGS) together with animal models has further elucidated its molecular pathogenesis, identifying novel genes/pathways. Mutations of >60 genes emphasize high genetic heterogeneity. Genome-wide association studies have revealed a shared genetic background between POI and reproductive aging. NGS will provide a genetic diagnosis leading to genetic/therapeutic counseling: first, defects in meiosis or DNA repair genes may predispose to tumors; and second, specific gene defects may predict the risk of rapid loss of a persistent ovarian reserve, an important determinant in fertility preservation. Indeed, a recent innovative treatment of POI by in vitro activation of dormant follicles proved to be successful.",
keywords = "exome, genetics, in vitro activation of dormant follicles, meiosis genes, ovary, primary ovarian insufficiency",
author = "Ilpo Huhtaniemi and Outi Hovatta and {La Marca}, Antonio and Gabriel Livera and Danielle Monniaux and Luca Persani and Abdelkader Heddar and Katarzyna Jarzabek and Triin Laisk-Podar and Andres Salumets and Tapanainen, {Juha S.} and Veitia, {Reiner A.} and Visser, {Jenny A.} and Peter Wieacker and Slawomir Wolczynski and Micheline Misrahi",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.tem.2018.03.010",
language = "English",
volume = "29",
pages = "400--419",
journal = "Trends in Endocrinology and Metabolism",
issn = "1043-2760",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency

AU - Huhtaniemi, Ilpo

AU - Hovatta, Outi

AU - La Marca, Antonio

AU - Livera, Gabriel

AU - Monniaux, Danielle

AU - Persani, Luca

AU - Heddar, Abdelkader

AU - Jarzabek, Katarzyna

AU - Laisk-Podar, Triin

AU - Salumets, Andres

AU - Tapanainen, Juha S.

AU - Veitia, Reiner A.

AU - Visser, Jenny A.

AU - Wieacker, Peter

AU - Wolczynski, Slawomir

AU - Misrahi, Micheline

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Primary ovarian insufficiency (POI) affects ∼1% of women before 40 years of age. The recent leap in genetic knowledge obtained by next generation sequencing (NGS) together with animal models has further elucidated its molecular pathogenesis, identifying novel genes/pathways. Mutations of >60 genes emphasize high genetic heterogeneity. Genome-wide association studies have revealed a shared genetic background between POI and reproductive aging. NGS will provide a genetic diagnosis leading to genetic/therapeutic counseling: first, defects in meiosis or DNA repair genes may predispose to tumors; and second, specific gene defects may predict the risk of rapid loss of a persistent ovarian reserve, an important determinant in fertility preservation. Indeed, a recent innovative treatment of POI by in vitro activation of dormant follicles proved to be successful.

AB - Primary ovarian insufficiency (POI) affects ∼1% of women before 40 years of age. The recent leap in genetic knowledge obtained by next generation sequencing (NGS) together with animal models has further elucidated its molecular pathogenesis, identifying novel genes/pathways. Mutations of >60 genes emphasize high genetic heterogeneity. Genome-wide association studies have revealed a shared genetic background between POI and reproductive aging. NGS will provide a genetic diagnosis leading to genetic/therapeutic counseling: first, defects in meiosis or DNA repair genes may predispose to tumors; and second, specific gene defects may predict the risk of rapid loss of a persistent ovarian reserve, an important determinant in fertility preservation. Indeed, a recent innovative treatment of POI by in vitro activation of dormant follicles proved to be successful.

KW - exome

KW - genetics

KW - in vitro activation of dormant follicles

KW - meiosis genes

KW - ovary

KW - primary ovarian insufficiency

UR - http://www.scopus.com/inward/record.url?scp=85046116318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046116318&partnerID=8YFLogxK

U2 - 10.1016/j.tem.2018.03.010

DO - 10.1016/j.tem.2018.03.010

M3 - Review article

AN - SCOPUS:85046116318

VL - 29

SP - 400

EP - 419

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

SN - 1043-2760

IS - 6

ER -